BamSEC and AlphaSense Join Forces
Learn More

Aspire Biopharma Holdings Inc. – Plans of Reorganization, Merger, Acquisition or Similar

NASDAQ: ASBP    
Share price (3/20/26): $0.72    
Market cap (3/20/26): $3.608 million

Plans of Reorganization, Merger, Acquisition or Similar Filter

EX-2.1
from 425 3 pages Second Amendment Agreement
12/34/56
EX-2.1
from 8-K 3 pages Second Amendment Agreement
12/34/56
EX-2.1
from 8-K 4 pages Promissory Note Fee Agreement
12/34/56
EX-2.1
from 425 4 pages Promissory Note Fee Agreement
12/34/56
EX-2.1
from 8-K 3 pages Amendment Agreement
12/34/56
EX-2.1
from 425 3 pages Amendment Agreement
12/34/56
EX-2.1
from 425 76 pages Agreement and Plan of Merger by and Among PowerUp Acquisition Corp., as the Purchaser, Powerup Merger Sub II, Inc., as Merger Sub, Srirama Associates, LLC, as the Sponsor, Stephen Quesenberry as the Seller Representative, and Aspire Biopharma, Inc., as the Company Dated as of August 26, 2024
12/34/56
EX-2.1
from 8-K 76 pages Agreement and Plan of Merger by and Among PowerUp Acquisition Corp., as the Purchaser, Powerup Merger Sub II, Inc., as Merger Sub, Srirama Associates, LLC, as the Sponsor, Stephen Quesenberry as the Seller Representative, and Aspire Biopharma, Inc., as the Company Dated as of August 26, 2024
12/34/56
EX-2.1
from 425 4 pages Amendment Agreement
12/34/56
EX-2.1
from 8-K 4 pages Amendment Agreement
12/34/56
EX-2.1
from 8-K 76 pages Agreement and Plan of Merger by and Among PowerUp Acquisition Corp., as the Purchaser, Powerup Merger Sub Inc., as Merger Sub, Srirama Associates, LLC, as the Sponsor, Ryan Bleeks, as the Seller Representative, and Visiox Pharmaceuticals, Inc., as the Company Dated as of December 26, 2023
12/34/56
EX-2.1
from 425 76 pages Agreement and Plan of Merger by and Among PowerUp Acquisition Corp., as the Purchaser, Powerup Merger Sub Inc., as Merger Sub, Srirama Associates, LLC, as the Sponsor, Ryan Bleeks, as the Seller Representative, and Visiox Pharmaceuticals, Inc., as the Company Dated as of December 26, 2023
12/34/56